MAAT INDEX

CLAIM #33987 · Johnson & Johnson (JNJ) · 2024Q4 earnings call · Jan 22, 2025 · due Dec 31, 2027

We're confident in our expectations communicated at the EBR. And as a reminder, we expect our end markets to grow between 5% and 7% on a weighted average basis between 22% and 27%.

Joseph Wolk · CFO

PENDING
graded after results covering Dec 31, 2027 are reported

How to check this claim

Look at: Weighted-average growth rate of company's end markets, as referenced from the Enterprise Business Review (EBR) targets

It came true if: Weighted average end-market growth between 5% and 7%, cumulative/annualized through the stated period, based on company-disclosed figures

Where: Company management commentary (earnings calls, investor presentations, EBR follow-up disclosures) through 2027

Verify independently

SEC filings for JNJ · Claim quote is verbatim from the 2024Q4 earnings call.